ExodusPoint Capital Management, LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,687
+477.8%
345,814
+620.0%
0.03%
+550.0%
Q2 2023$465
+6.9%
48,032
+21.1%
0.00%0.0%
Q1 2023$435
+175.3%
39,678
+8.6%
0.00%
+100.0%
Q4 2022$158
-100.0%
36,522
-79.8%
0.00%
-90.9%
Q2 2022$1,814,000
-5.1%
180,472
+16.9%
0.02%
-8.3%
Q1 2022$1,911,000
-43.5%
154,324
+4.4%
0.02%
-31.4%
Q4 2021$3,380,000
+2199.3%
147,799
+1203.8%
0.04%
+1650.0%
Q1 2021$147,000
-54.6%
11,336
-48.4%
0.00%
-66.7%
Q3 2020$324,000
+113.2%
21,988
-22.6%
0.01%
+20.0%
Q3 2019$152,00028,4000.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders